The current study is aimed at using the TCGA database to locate the gene BTG2 as a downregulated gene and predict prognosis and survival in LUAD patients, developing the human lung adenocarcinoma A549 cell line with BTG2 overexpression, and investigating its function experiments to assess its role in tumor progression. This evidence concerns the gene BTG2 and neoplasm.